What does the evidence say about Cinnamon Glycemic Markers Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Cinnamon Glycemic Markers Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - The consumption of metformin and cinnamon significantly decreased insulin resistance (HOMA-IR) in comparison to the placebo and ginger groups ( P P Conclusion Our findings suggest that in women with PCOS, cinnamon supplementation causes similar reductions in insulin resistance and testosterone level to that of metformin. [Dastgheib M (2022); evidence level 2] - Background/objectives Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder in women that can alter blood glucose, lipid profile and sexual hormonal level. [Dastgheib M (2022); evidence level 2] - Therefore, the evaluation of potential therapeutic agents in this population is important. [Dastgheib M (2022); evidence level 2] - Prediabetes typically precedes the diagnosis of type 2 diabetes, which accounts for increased morbidity and mortality. [Feinberg T (2019); evidence level 2] - This study aims to evaluate the safety and efficacy of a commercially available dietary supplement in the popular, but as yet insufficiently studied, category of polyherbal formulas for the management of glycemic parameters and other biomarkers associated with prediabetes. [Feinberg T (2019); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.